Select Committee on Science and Technology Appendices to the Minutes of Evidence


APPENDIX 19

Memorandum submitted by the Leukaemia Research Fund

  The virtual National Cancer Research Institute has provided a welcome focus for cancer funding agencies to work together in a strategic partnership. The creation of a common UK research database is an important and worthy first goal for NCRI. The simultaneous establishment of the National Cancer Research Network has created a co-ordinated infrastructure for the speedy delivery of well conducted and informative clinical trials in combination with integrated laboratory-based research projects. A review of UK trial offices and their output is one of the first tasks of NCRN. The aim of the review will be to create a clearly defined environment for agencies within NCRI to invest in internationally competitive trials and research. The targets set for patient accrual and the timetable for the completion of trials are tough but achievable. My initial conclusions both as a member of the NCRI Board and the NCRN Steering Committee are that these dual initiatives have been embraced with energy and enthusiasm by cancer physicians and scientists. It is now crucial to build on this positive start and to demonstrate to the UK cancer research community that by working within NCRI and NCRN the whole of UK cancer research can be greater than the sum of the parts. If successful, progress in cancer diagnosis and treatment should be greatly accelerated.

Dr David Grant

Scientific Director

6 December 2001


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2002
Prepared 20 March 2002